Genomic Valley Biotech Limited (BOM:539206)

Genomic Valley Biotech Revenue

In the fiscal year ending March 31, 2026, Genomic Valley Biotech had annual revenue of 2.68M INR, down -68.30%. Genomic Valley Biotech had revenue of 375.00K in the quarter ending March 31, 2026, a decrease of -85.77%.

• Revenue: 2.68M
• Revenue Growth: -68.30%
• P/S Ratio: 40.09
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 107.24M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.68M	-5.76M	-68.30%
Mar 31, 2025	8.44M	6.79M	411.25%
Mar 31, 2024	1.65M	-25.57M	-93.94%
Mar 31, 2023	27.23M	26.52M	3,758.23%
Mar 31, 2022	705.64K	-1.38M	-66.09%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error